Patient Capital: Why the Best Ideas Are Worth the Wait

The best ideas are almost never the fastest. That is inconvenient, and it is also more or less the whole point.

There is a phrase that gets used a good deal and examined rather less: patient capital. It describes money that is willing to wait, backing an idea and then giving it the years it actually needs rather than the months a calendar would prefer. Nicole Junkermann has come to think of patience less as a virtue and more as a competitive advantage, one that is available to anyone prepared to be a little unfashionable about time. Almost everyone claims to think long term. Very few are willing to be judged that way, and the gap between the two is where the interesting opportunities tend to sit.

The tyranny of the quick answer

We live inside a culture tuned for speed. Messages are answered in seconds, results are reported by the quarter, and a thing that has not proved itself by the end of the year is quietly assumed to have failed. Some of that pace is genuinely useful. A great deal of it is simply noise dressed as urgency. The trouble is that the ideas that end up mattering most tend to keep a different clock entirely. A new material, a new treatment, a new way of doing a very old thing: these ripen over years, and no amount of pressure makes them ripen faster. Patient capital is money that understands this and behaves accordingly. It is not cleverer than the impatient kind. It is calmer.

What a long horizon actually buys

Patience is not passive, and it is certainly not free. What it buys, though, is worth the cost. It buys the room to be wrong on the way to being right, which is how almost everything difficult gets done. It buys the trust of the people doing the work, who can build the thing properly instead of building for the next review. Above all it buys time for compounding, that quiet and slightly magical process by which small, steady gains stack on top of one another until, seen from far enough away, they look like a sudden leap. Nobody notices compounding while it is happening. Everybody notices the result.

Telling a slow idea from a stalled one

Patience is not an excuse to ignore the evidence, and waiting is not the same as hoping. The harder skill is telling an idea that is simply slow from one that has quietly stopped. Nicole Junkermann keeps a rough set of tells for the kind of idea that rewards a long wait.

• It answers a real problem, one that will still be a problem in ten years.
• It grows sturdier rather than more fragile as it gets larger.
• The people behind it think in decades and talk in specifics.
• It would be hard to copy even if a rival were handed the plans.
• Its best version is one that nobody can quite picture yet.

None of these is a guarantee. Together they describe something that is worth the discomfort of waiting, as opposed to something that is merely taking a long time to disappoint you.

Waiting is a form of work

The part that gets left out of the story is how much waiting takes. It is easy to be patient in the first flush of enthusiasm and easy again once success has arrived. The test is the long middle, the stretch where the early excitement has worn off, the results are ambiguous, and every instinct is to do something, anything, to feel busy. Real patience is active. It is attention without interference, steadiness through the dip, and the discipline to keep backing a thing when it would be far more comfortable to move on. It also means holding your nerve when the loudest voices in the room have already lost theirs, which is more often than not the moment just before things turn. That is the work, and most of it happens where no one is watching.

Why the wait is worth it

The reward for all this is not only financial, though the arithmetic of compounding tends to look after those who leave it undisturbed. The deeper reward is that patient capital is how the genuinely new gets built at all. The fast money can only fund what is already legible, the ideas that fit neatly into a short horizon. Everything more ambitious than that, the treatment that takes a decade, the business that takes a generation, depends on someone being willing to wait. It is the same instinct, on a smaller scale, that Nicole Junkermann finds in the slow, long-dated work explored in what a large commitment to UK life sciences tells us about Britain's future. The best ideas are worth the wait for a simple reason: waiting is the price of admission to the ideas that are actually worth having.

More from Nicole Junkermann

For more from Nicole Junkermann, read the full profile of Nicole Junkermann, browse her favourite books on business and ideas, or visit the Notebook.

← Back to the blog